Print This Page
Special Presentation on New Treatments in Multiple Myeloma
Dr. Asher Chanan-Khan, Department of Medicine, RPCI, participated in a live internet webcast of Patient Power on February 1 at 3pm Eastern. The topic is new treatments in multiple myeloma. THIS WEBCAST CAN BE VIEWED ON DEMAND AT: http://patientpower.info/programreplays.asp as soon as it's posted. This seventh program in our multiple myeloma series features Dr. Paul Richardson, clinical director of the Jerome Lipper Center for Multiple Myeloma at the Dana-Farber Cancer Institute in Boston and Dr. Asher Chanan-Khan, an attending physician in the Department of Medicine at Roswell Park Cancer Institute in Buffalo, N.Y. Both doctors agree this is a pivotal time for myeloma patients to consider participating in trials as we move to more effective treatments, leading to longer lives. We welcome your questions and encourage you to join the conversation by submitting them online now or during the live webcast. While we cannot answer every question nor give personal medical guidance on the program, your questions help highlight topics that are important to many people. See below.
Myeloma Series NewsletterDear Jamie, Welcome to our 2008 Patient Power series of myeloma webcasts. This year looks to be an exciting time for the continued rapid development of effective treatment combinations. With numerous drug approvals in the last four years and more coming, myeloma specialists are beginning to establish a “backbone” of effective drug therapies. Clinical trials are helping researchers understand new combinations of these drugs and which combination is right for which patient and when. We’ll hear from two leading investigators about the latest news in clinical trials for myeloma patients during a one-hour, special edition program which will air LIVE— online only at www.patientpower.info -- this Friday, Feb. 1, beginning at 3 p.m. Eastern, 12 p.m. Pacific. This seventh program in our multiple myeloma series features Dr. Paul Richardson, clinical director of the Jerome Lipper Center for Multiple Myeloma at the Dana-Farber Cancer Institute in Boston and Dr. Asher Chanan-Khan, an attending physician in the Department of Medicine at Roswell Park Cancer Institute in Buffalo, N.Y. Both doctors agree this is a pivotal time for myeloma patients to consider participating in trials as we move to more effective treatments, leading to longer lives. We welcome your questions and encourage you to join the conversation by submitting them online now or during the live webcast. While we cannot answer every question nor give personal medical guidance on the program, your questions help highlight topics that are important to many people. Details for how to attend this authoritative discussion and submit questions can be found at: http://www.patientpower.info/specialeditionmyeloma.asp. On the day of the program check back on this web page for a link to the LIVE audio. This page is also where the replay and full transcript will be posted. All the past replays and transcripts from our myeloma series are posted on www.patientpower.info. Please let friends and family know about this important program, and we hope you can join us. Remember, knowledge can be the best medicine of all. Andrew Schorr and the Patient Power Team ©2005 - 2007 Patient Power, LLC | Site by Rhizome Design |
| ||||||
